CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Yigen Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, West Yorkshire, UK. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Oncogene Proteins, Viral, Papillomavirus Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Human papillomaviruses (HPVs) infect the oral and anogenital mucosa and can cause cancer. The high‐risk (HR)‐HPV oncoproteins, E6 and E7, hijack cellular factors to promote cell proliferation, delay differentiation and induce genomic instability, thus predisposing infected cells to malignant transformation. cAMP response element (CRE)‐binding protein 1 (CREB1) is a master transcription factor that can function as a proto‐oncogene, the abnormal activity of which is associated with multiple cancers. However, little is known about the interplay between HPV and CREB1 activity in cervical cancer or the productive HPV lifecycle. We show that CREB is activated in productively infected primary keratinocytes and that CREB1 expression and phosphorylation is associated with the progression of HPV+ cervical disease. The depletion of CREB1 or inhibition of CREB1 activity results in decreased cell proliferation and reduced expression of markers of epithelial to mesenchymal transition, coupled with reduced migration in HPV+ cervical cancer cell lines. CREB1 expression is negatively regulated by the tumor suppressor microRNA, miR‐203a, and CREB1 phosphorylation is controlled through the MAPK/MSK pathway. Crucially, CREB1 directly binds the viral promoter to upregulate transcription of the E6/E7 oncogenes, establishing a positive feedback loop between the HPV oncoproteins and CREB1. Our findings demonstrate the oncogenic function of CREB1 in HPV+ cervical cancer and its relationship with the HPV oncogenes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, West Yorkshire, UK.
- Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, West Yorkshire, UK.
- School of Life Sciences, University of Sussex, Falmer, Brighton, UK.
- Leeds Institute of Rheumatic and Musculoskeletal Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, West Yorkshire, UK.
ORCID-Profile: Yigen Li, Ethan L Morgan, Andrew Macdonald
Förderung
- Medical Research Council
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Li, Y., Patterson, M. R., Morgan, E. L., Wasson, C. W., Ryder, E. L., Barba-Moreno, D., Scarth, J. A., Wang, M., & Macdonald, A. (2023). CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation. Journal of Medical Virology. https://doi.org/10.1002/jmv.29025
Vancouver
Li Y, Patterson MR, Morgan EL, Wasson CW, Ryder EL, Barba-Moreno D, et al. CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation. Journal of Medical Virology. 2023. doi:10.1002/jmv.29025
BibTeX
@article{Li2023,
author = {Li, Yigen and Patterson, Molly R and Morgan, Ethan L and Wasson, Christopher W and Ryder, Emma L and Barba-Moreno, Diego and Scarth, James A and Wang, Miao and Macdonald, Andrew},
title = {CREB1 activation promotes human papillomavirus oncogene expression and cervical cancer cell transformation},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29025}
}
EUVIMED